A New Approach to Regulating Heart Rhythms
Pacemakers have long served as the standard treatment for people with abnormal heart rhythms, helping the heart maintain a steady beat through electrical stimulation. However, doctors must surgically implant these devices, and patients may require additional procedures over time. To address these challenges, researchers at the Massachusetts Institute of Technology (MIT) have developed a wearable ultrasound patch that could offer a noninvasive alternative to traditional pacemakers.
The innovative device, about the size of a postage stamp, attaches directly to the chest. Instead of relying on implanted electrodes, the patch sends focused ultrasound waves through the body to stimulate heart tissue from outside. By doing so, it could eliminate the need for invasive surgery while still providing precise control over cardiac activity.
Harnessing the Power of Sound Waves
The researchers combined ultrasound technology with a technique known as sonogenetics. Using this approach, they engineered heart cells to become highly sensitive to sound waves. When the wearable patch emits ultrasound signals, specialized channels inside the cells open and allow calcium ions to flow in, triggering the contractions that keep the heart beating normally.
The team demonstrated that the patch can effectively control the timing and rhythm of heart contractions. Because ultrasound reaches deep tissues without surgical intervention, the technology offers a promising way to regulate heart function safely and efficiently.
Promising Results and Future Potential
During laboratory tests, the MIT team used the device to correct irregular heart rhythms and synchronize cardiac activity in engineered human heart cells and animal models. The researchers observed rapid responses, showing that the technology could potentially replace implanted pacemakers in certain situations.
Looking ahead, the scientists plan to integrate the patch with wearable monitoring systems that continuously track heart health. Such a device could automatically detect rhythm disturbances and deliver corrective stimulation when necessary. Although researchers must complete further testing and clinical trials before commercialization, this breakthrough moves wearable cardiac care one step closer to reality and highlights the growing potential of noninvasive medical technologies.
